5.10
price up icon8.05%   0.38
after-market After Hours: 5.05 -0.05 -0.98%
loading
Galectin Therapeutics Inc stock is traded at $5.10, with a volume of 515.54K. It is up +8.05% in the last 24 hours and down -5.03% over the past month. Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
See More
Previous Close:
$4.72
Open:
$4.82
24h Volume:
515.54K
Relative Volume:
1.70
Market Cap:
$326.71M
Revenue:
-
Net Income/Loss:
$-45.08M
P/E Ratio:
-6.9863
EPS:
-0.73
Net Cash Flow:
$-33.68M
1W Performance:
+14.86%
1M Performance:
-5.03%
6M Performance:
+277.78%
1Y Performance:
+88.89%
1-Day Range:
Value
$4.73
$5.35
1-Week Range:
Value
$4.47
$5.35
52-Week Range:
Value
$0.726
$6.55

Galectin Therapeutics Inc Stock (GALT) Company Profile

Name
Name
Galectin Therapeutics Inc
Name
Phone
678-620-3186
Name
Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
Name
Employee
15
Name
Twitter
@galectingalt
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
GALT's Discussions on Twitter

Compare GALT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GALT
Galectin Therapeutics Inc
5.10 302.36M 0 -45.08M -33.68M -0.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-17-25 Resumed H.C. Wainwright Buy
Aug-13-20 Reiterated H.C. Wainwright Buy
Feb-13-19 Initiated B. Riley FBR Buy
Dec-07-17 Reiterated H.C. Wainwright Buy
Nov-28-17 Reiterated H.C. Wainwright Buy
Oct-19-17 Initiated ROTH Capital Buy
Mar-30-17 Upgrade H.C. Wainwright Neutral → Buy
Oct-03-16 Downgrade FBR & Co. Outperform → Mkt Perform
Sep-29-16 Downgrade H.C. Wainwright Buy → Neutral
Sep-28-16 Downgrade ROTH Capital Buy → Sell
Mar-28-16 Resumed H.C. Wainwright Buy
Sep-21-15 Initiated H.C. Wainwright Buy
Aug-01-14 Downgrade Aegis Capital Buy → Hold
Jul-30-14 Reiterated MLV & Co Buy
Jul-29-14 Reiterated MLV & Co Buy
Apr-02-14 Reiterated MLV & Co Buy
Feb-10-14 Reiterated Aegis Capital Buy
Jan-09-14 Reiterated Aegis Capital Buy
Dec-03-13 Initiated MLV & Co Buy
Aug-19-13 Reiterated Aegis Capital Buy
View All

Galectin Therapeutics Inc Stock (GALT) Latest News

pulisher
10:56 AM

Identifying reversal signals in Galectin Therapeutics Inc.July 2025 Price Swings & High Return Trade Guides - newser.com

10:56 AM
pulisher
10:19 AM

Short interest data insights for Galectin Therapeutics Inc.Weekly Investment Recap & Weekly Watchlist of Top Performers - newser.com

10:19 AM
pulisher
Oct 10, 2025

Can machine learning forecast Galectin Therapeutics Inc. recoveryJuly 2025 Summary & High Yield Equity Trading Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Trend analysis for Galectin Therapeutics Inc. this weekQuarterly Investment Review & Reliable Volume Spike Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Galectin Therapeutics Inc Stock Analysis and ForecastMarket Depth Overview & Big Profit Low Trading - earlytimes.in

Oct 09, 2025
pulisher
Oct 09, 2025

Galectin Therapeutics' (GALT) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 08, 2025

Should Dividend Investors Consider Omnipotent Industries Limited in YEAREconomic Data Impact & Free Dashboard to Track Market Momentum - earlytimes.in

Oct 08, 2025
pulisher
Oct 08, 2025

Is Galectin Therapeutics Inc a good long term investmentChart Pattern Recognition & Connect With Bulls, Avoid the Bears - earlytimes.in

Oct 08, 2025
pulisher
Oct 07, 2025

Prevents Varices at 18 Months — Galectin Therapeutics to Present NAVIGATE Data at AASLD Nov 10 - Stock Titan

Oct 07, 2025
pulisher
Oct 06, 2025

Will Galectin Therapeutics Inc. (PHPN) stock hit Wall Street targetsJuly 2025 Price Swings & Verified Stock Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How sentiment analysis helps forecast Galectin Therapeutics Inc.July 2025 Decliners & Verified Short-Term Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Market reaction to Galectin Therapeutics Inc.’s recent newsQuarterly Market Review & Fast Gain Stock Trading Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Galectin Therapeutics Inc. (PHPN) stock cheap by valuation metricsPortfolio Update Summary & Weekly Breakout Opportunity Watchlist - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World

Oct 03, 2025
pulisher
Oct 03, 2025

Will Galectin Therapeutics Inc. (PHPN) stock beat growth indexesJuly 2025 Summary & Daily Price Action Insights - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Analyzing Galectin Therapeutics Inc. with risk reward ratio charts2025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

Using R and stats models for Galectin Therapeutics Inc. forecastingWeekly Trade Recap & Accurate Trade Setup Notifications - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Chart overlay techniques for tracking Galectin Therapeutics Inc.July 2025 Recap & Precise Swing Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

What drives Galectin Therapeutics Inc PHPN stock pricePrice Momentum Alerts & High Yield Market Growth - earlytimes.in

Sep 29, 2025
pulisher
Sep 28, 2025

What drives Galectin Therapeutics Inc stock priceDouble Top/Bottom Patterns & Free Double Digit Growth Tips - earlytimes.in

Sep 28, 2025

Galectin Therapeutics Inc Stock (GALT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Galectin Therapeutics Inc Stock (GALT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
CALLICUTT JACK W
Chief Financial Officer
Sep 12 '25
Sale
6.44
8,706
56,054
7,614
LEWIS JOEL
President and CEO
Sep 12 '25
Option Exercise
2.39
14,000
33,460
846,592
LEWIS JOEL
President and CEO
Sep 12 '25
Sale
6.36
14,000
89,048
832,592
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):